NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 6 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Sacheerome H1 FY27 Net Profit Up 12.4% to ₹16.79 Cr; YEIDA Plant Ready for Commercial Launch
Sacheerome Limited published its H1 FY27 earnings call transcript following results where total income rose 9.84% YoY to ₹85.92 crore and net profit grew 12.38% YoY to ₹16.79 crore. EBITDA increased by 12.27% to ₹23.69 crore, resulting in an EBITDA margin of 27.57%. Management highlighted that trial production at its ₹184 crore YEIDA manufacturing facility commenced in September 2026, with ₹110 crore capex incurred as of September 30, 2026. The facility is awaiting final statutory certificates before initiating commercial production.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript for the H1 FY27 earnings conference call held on November 4, 2026.
ஏன் இது முக்கியம்Provides detailed operational insights into the ₹184 crore YEIDA facility expansion, which is poised to scale up manufacturing capacity once final regulatory certificates arrive.
H1 FY27 Total Income: ₹85.92 கோடிH1 FY27 Net Profit: ₹16.79 கோடிH1 FY27 EBITDA Margin: 27.57%YEIDA Total Capex: approximately ₹184 croresYEIDA Capex Incurred (to Sept 2026): approximately ₹110 crores
📅 குறுகிய காலம்Stable operational performance with investor attention focused on timeline updates for final statutory clearances for the YEIDA plant.
📈 நீண்ட காலம்Commercialization of the automated, green YEIDA smart facility is expected to enhance production volume, in-house R&D, and export capabilities over multi-year horizons.
⚠ அபாய எச்சரிக்கைகள்
Delays in receipt of pending final statutory certificates for commercial operation
Ramp-up and capacity utilization risks at the new plant
👀 கவனிக்க வேண்டியவை
Track the receipt of final statutory certificates and the formal announcement of commercial production commencement at the new YEIDA plant over the coming quarters.
Sacheerome H1 FY27 Total Income Up 9.84% to ₹85.92 Cr; Trial Production Starts at YEIDA
Sacheerome Limited published its H1 FY27 investor presentation, reporting total income of ₹85.92 crore (₹8,591.98 lakhs), an increase of 9.84% YoY from ₹78.22 crore. EBITDA grew 12.27% YoY to ₹23.69 crore, with EBITDA margin expanding slightly to 27.57% from 26.98%. Profit after tax (PAT) rose 12.38% YoY to ₹16.79 crore. Additionally, the company commenced trial production at its new YEIDA facility in September 2026, which will expand manufacturing and R&D capabilities.
உச்சம் நம்பிக்கை
என்ன மாறியதுSacheerome released its H1 FY27 performance deck detailing 12.38% PAT growth and confirming the start of trial production at the new YEIDA plant in September 2026.
ஏன் இது முக்கியம்The new YEIDA facility adds key manufacturing, R&D, and testing capacity beyond its legacy New Delhi plant, which supports long-term volume growth in fragrances and flavours.
H1 FY27 Total Income: ₹8,591.98 லட்சம்H1 FY27 EBITDA: ₹2,369.15 லட்சம்H1 FY27 PAT: ₹1,678.68 லட்சம்EBITDA Margin H1 FY27: 27.57%Annual Production Capacity: 27,60,000 Kg
📅 குறுகிய காலம்Stable operational performance and high operating margins (~27.6%) provide near-term earnings resilience.
📈 நீண்ட காலம்The operationalization of the YEIDA facility and expansion into global FMCG and GCC markets will determine future scalability and revenue acceleration.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility affecting fragrance and flavour chemical inputs
Execution and ramp-up risks at the newly commissioned YEIDA facility
👀 கவனிக்க வேண்டியவை
Track the commercial launch timeline and capacity ramp-up at the YEIDA manufacturing plant, alongside customer additions in export markets like the Middle East.
H1 FY27 PAT Rises 12.4% to ₹1,678.68 Lakh; YEIDA Facility Begins Trial Runs
Sacheerome Limited reported a 9.84% YoY increase in H1 FY27 total income to ₹8,591.98 lakh compared to ₹7,822.36 lakh in H1 FY26. EBITDA grew 12.27% YoY to ₹2,369.15 lakh, delivering an EBITDA margin of 27.57%. Profit after tax increased 12.38% YoY to ₹1,678.68 lakh with a PAT margin of 19.54%. Additionally, the company announced the completion of installation and commissioning of its new Smart Green Factory at YEIDA, where trial production commenced in September 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSacheerome reported steady H1 FY27 financial performance and progressed its YEIDA facility from commissioning into trial production in September 2026.
ஏன் இது முக்கியம்The operationalization of the YEIDA facility expands manufacturing capacity and adds dedicated R&D and application centres, enabling volume scale-up in domestic and export markets.
📅 குறுகிய காலம்Stable performance with near 10% revenue growth and healthy margins should provide steady market sentiment.
📈 நீண்ட காலம்The commercialization of the YEIDA greenfield facility will drive medium-to-long term volume growth and support deeper penetration into B2B FMCG fragrance and flavour markets.
⚠ அபாய எச்சரிக்கைகள்
Execution delays in moving from trial production to full commercial operations at YEIDA
Capacity ramp-up and fixed-cost absorption risks in initial operating quarters
👀 கவனிக்க வேண்டியவை
Track the timeline for commercial production commencement at the new YEIDA facility and monitor subsequent margin performance as operational overheads scale up.
Sacheerome H1 FY27 Revenue Up 10.34% to ₹84.48 Cr; Trial Production Begins at YEIDA Facility
Sacheerome Limited reported its H1 FY27 business update, posting revenue of ₹84.48 crore, reflecting a 10.34% YoY growth. The company successfully completed installation and commissioning of its new Smart Green Factory at YEIDA, beginning trial production in September 2026. As of September 30, 2026, total annual production capacity stands at 27,60,000 kg across two manufacturing units, supported by 60 R&D specialists. The figures provided are management estimates and remain subject to final audit adjustments.
உச்சம் நம்பிக்கை
என்ன மாறியதுSacheerome commissioned its new YEIDA manufacturing facility and initiated trial production in September 2026.
ஏன் இது முக்கியம்The new facility expands manufacturing capacity, houses specialized R&D and consumer evaluation centres, and supports medium-to-long-term volume growth in domestic and export markets.
📅 குறுகிய காலம்Positive sentiment driven by double-digit revenue growth and operational progress at the YEIDA plant, though figures remain provisional estimates.
📈 நீண்ட காலம்The additional capacity from the YEIDA Smart Green Factory positions the company to scale supply to FMCG clients and expand international fragrance and flavour footprints.
⚠ அபாய எச்சரிக்கைகள்
Figures are provisional management estimates subject to audit
Commercial ramp-up and execution risks post-trial production
👀 கவனிக்க வேண்டியவை
Track the timeline for commercial production commencement at the YEIDA facility and observe volume ramp-up and margins when full audited H1 results are released.
Sacheerome Commences Trial Production at New YEIDA Manufacturing Plant
Sacheerome Limited has announced the completion of installation and commissioning at its new manufacturing plant located at YEIDA, Uttar Pradesh. The company has officially commenced trial production at the facility as of September 30, 2026. This filing follows an earlier intimation dated August 29, 2026, regarding the project progress. Specific capacity additions, capex outlays, and commercial production timelines were not disclosed in the filing.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுThe company completed installation and commissioning and started trial production at its new YEIDA facility.
ஏன் இது முக்கியம்Commencing trials marks the final stage before full commercial operations, which will expand manufacturing capabilities and support long-term volume growth.
👀 கவனிக்க வேண்டியவை
Track subsequent announcements regarding the successful completion of trials, transition to full commercial operations, and disclosure of added capacity figures.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Sacheerome Releases FY26 Investor Deck: FY26 Revenue at ₹152.39 Cr, PAT at ₹28.44 Cr
Sacheerome Limited published its H2 FY26 & FY26 investor presentation detailing financial performance and strategic updates. For FY26, the company posted revenue of ₹15,238.58 lakh (₹152.39 crore), EBITDA of ₹4,066.15 lakh (₹40.66 crore), and PAT of ₹2,844.11 lakh (₹28.44 crore). Return ratios remained robust with ROE at 27.04% and ROCE at 36.32%. The company continues construction of its new manufacturing facility in YEIDA, Uttar Pradesh, to scale beyond its current 7,60,000 kg annual capacity.
உச்சம் நம்பிக்கை
என்ன மாறியதுSacheerome released its comprehensive H2 FY26 & FY26 investor presentation outlining annual financial results, balance sheet health, and expansion status.
ஏன் இது முக்கியம்Provides investors detailed visibility into business margins, return ratios, balance sheet liquidity, and the progress of its greenfield manufacturing expansion in YEIDA.
📅 குறுகிய காலம்Informational deck providing reference figures; unlikely to trigger sharp near-term price movement unless new guidance is inferred.
📈 நீண்ட காலம்Commissioning of the YEIDA facility will determine volume growth and operating leverage in the fragrance and flavour segments over the coming years.
⚠ அபாய எச்சரிக்கைகள்
Execution and commissioning timelines for the new YEIDA manufacturing facility
Raw material price volatility in aroma chemicals and natural extracts
👀 கவனிக்க வேண்டியவை
Track the commercial commissioning timeline and capex capitalization of the upcoming YEIDA facility, alongside export growth in the Middle East and North American markets.
Sacheerome delays YEIDA unit commercial operations to August 2026 due to vendor issues
Sacheerome Limited has announced a revision in the implementation timeline for its new manufacturing unit at YEIDA, Uttar Pradesh. The commercial operations date has been pushed to August 2026, representing a 5-month delay from the original March 2026 timeline disclosed in the prospectus. The company cited vendor delays as the primary reason for the rescheduling. While the project scope remains unchanged, final building facade and landscaping work are now expected to extend into September 2026, with interior work continuing until November 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has extended the completion timelines for its new YEIDA manufacturing facility, shifting the start of commercial operations from March 2026 to August 2026.
ஏன் இது முக்கியம்Delays in commissioning new manufacturing capacity typically lead to deferred revenue generation and potential cost overruns, impacting the company's short-to-medium term growth trajectory.
Original Commercial Ops Date: மார்ச் 2026Revised Commercial Ops Date: ஆகஸ்ட் 2026Building Completion (Facade): செப்டம்பர் 2026Interior Work Completion: நவம்பர் 2026Project Location: YEIDA, Uttar Pradesh
📅 குறுகிய காலம்The stock may face minor pressure as the market adjusts for the delay in revenue contribution from the new facility.
📈 நீண்ட காலம்The long-term structural impact is limited as the project scope remains unchanged, provided the company successfully commences operations by the revised August 2026 date.
⚠ அபாய எச்சரிக்கைகள்
Execution risk
Vendor dependency
Potential cost overruns due to timeline extensions
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to meet the new August 2026 operational deadline and watch for any impact on FY27 revenue projections due to the 5-month delay in capacity commissioning.
Sacheerome to Start New YEIDA Facility in August 2026; Annual Capacity at 7.6 Lakh KG
Sacheerome Limited has announced its Q1 FY27 business update, highlighting the imminent commissioning of its second manufacturing facility at YEIDA, Uttar Pradesh, in August 2026. The company currently maintains an annual capacity of 7,60,000 kg and employs 59 R&D specialists to serve its B2B FMCG client base. The new integrated facility will house dedicated R&D, Quality Control, and Consumer Evaluation centers to support premium product development. Management is also prioritizing export expansion into the Middle East and GCC markets to drive international growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from the construction phase to the final commissioning stage of its second manufacturing unit, with a confirmed operational target of August 2026.
ஏன் இது முக்கியம்Doubling the number of manufacturing units (from 1 to 2) provides the necessary headroom for volume growth and enhances R&D capabilities to capture higher-margin premium fragrance and flavour segments.
Annual Capacity: 7,60,000 kgR&D Specialists: 59Operational Units: 1Units Under Construction: 1Expected Commencement Date: ஆகஸ்ட் 2026
📅 குறுகிய காலம்Positive sentiment is likely as the company nears the operationalization of its new plant, which is a major milestone for the current fiscal year.
📈 நீண்ட காலம்The new facility and R&D focus position the company to scale its B2B relationships with large FMCG brands and expand its international footprint structurally.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in the final commissioning of the YEIDA facility
Potential for initial margin pressure due to higher depreciation and operating costs of the new unit
👀 கவனிக்க வேண்டியவை
Watch for the formal commissioning announcement of the YEIDA facility in August 2026 and subsequent utilization rates in the Q2 and Q3 results.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
